H.I.G. HealthBridge Partners
H.I.G. HealthBridge Partners is a growth equity fund that collaborates with growth-stage healthcare companies to enhance patient outcomes while reducing healthcare costs. The firm focuses on sectors such as medical devices, biopharmaceuticals, digital health, tools and diagnostics, and product-related services. With a seasoned investment team, H.I.G. HealthBridge Partners provides strategic support to its portfolio companies in areas like market strategy, growth initiatives, and operational excellence.
Industries
N/A
Nr. of Employees
small (1-50)
H.I.G. HealthBridge Partners
1450 Brickell Avenue, 31st Floor, Miami, FL 33131
Portfolio
Awarded 'Most Innovative Product of the Year' by Best in Biz for CYTALUX® (pafolacianine) injection.
#Healthcare
H.I.G. Capital completed the sale of BIOVECTRA, a leading company in its sector.
#Healthcare
Received start-up financing of $207.8 million, one of the largest initial financing commitments for a European-focused biopharmaceutical company.
#Biopharmaceuticals
Developed the OverStitch™ Endoscopic Suturing System, a new class of flexible surgical instruments.
#Medical Devices
Pioneer in augmented reality surgical navigation, raised $82.5 million to accelerate adoption of augmented reality spine surgery.
#Medical Devices
Awarded 'Most Innovative Product of the Year' by Best in Biz for CYTALUX® (pafolacianine) injection.
#Healthcare
H.I.G. Capital completed the sale of BIOVECTRA, a leading company in its sector.
#Healthcare
Received start-up financing of $207.8 million, one of the largest initial financing commitments for a European-focused biopharmaceutical company.
#Biopharmaceuticals
Developed the OverStitch™ Endoscopic Suturing System, a new class of flexible surgical instruments.
#Medical Devices
Pioneer in augmented reality surgical navigation, raised $82.5 million to accelerate adoption of augmented reality spine surgery.
#Medical Devices